ArticleNeuro-oncology advances

Correction to: Recurrent fibroblast growth factor receptor3 fusion glioblastoma treated with pemigatinib: A case report and review of the literature.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.